risedronic acid has been researched along with Femoral Fractures in 12 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Femoral Fractures: Fractures of the femur.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We did not find evidence for a reversal of fracture protection with long-term use of bisphosphonates." | 1.38 | Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases. ( Abrahamsen, B; Pazianas, M; Russell, RG; Wang, Y, 2012) |
| "Up to 80-90% of patients with treatment-requiring osteoporosis are not receiving specific treatment." | 1.31 | [Weeks of pain, vertebral body fractures during sleep, invalidism. Save your osteoporosis patients from this fate]. ( Begerow, B; Hinz, C; Minne, HW; Pfeifer, M; Pollähne, W, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ke, CH | 1 |
| Li, HY | 1 |
| Yang, D | 1 |
| Ying, H | 1 |
| Xu, J | 1 |
| Wang, J | 1 |
| Zhu, HW | 1 |
| Wang, L | 1 |
| Leclerc, JT | 1 |
| Michou, L | 1 |
| Vaillancourt, F | 1 |
| Pelet, S | 1 |
| Simonyan, D | 1 |
| Belzile, EL | 1 |
| Gopal, GK | 1 |
| Tam, KL | 1 |
| Krishnan, SP | 1 |
| Maddern, IL | 1 |
| Schilcher, J | 2 |
| Koeppen, V | 1 |
| Aspenberg, P | 2 |
| Michaëlsson, K | 1 |
| Koh, JH | 1 |
| Myong, JP | 1 |
| Jung, SM | 1 |
| Lee, J | 1 |
| Kwok, SK | 1 |
| Park, SH | 1 |
| Ju, JH | 1 |
| Hyodo, K | 1 |
| Nishino, T | 1 |
| Kamada, H | 1 |
| Nozawa, D | 1 |
| Mishima, H | 1 |
| Yamazaki, M | 1 |
| Girgis, CM | 1 |
| Sher, D | 1 |
| Seibel, MJ | 1 |
| Fahlgren, A | 1 |
| Kľoc, P | 1 |
| Tomčovčík, L | 1 |
| Kľoc, J | 1 |
| Ott, SM | 1 |
| Pazianas, M | 1 |
| Abrahamsen, B | 1 |
| Wang, Y | 1 |
| Russell, RG | 1 |
| Minne, HW | 1 |
| Pollähne, W | 1 |
| Pfeifer, M | 1 |
| Begerow, B | 1 |
| Hinz, C | 1 |
1 review available for risedronic acid and Femoral Fractures
| Article | Year |
|---|---|
What is the optimal duration of bisphosphonate therapy?
Topics: Alendronate; Biomarkers; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Femoral F | 2011 |
1 trial available for risedronic acid and Femoral Fractures
| Article | Year |
|---|---|
Prevalence and Characteristics of Atypical Periprosthetic Femoral Fractures.
Topics: Aged; Aged, 80 and over; Alendronate; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2019 |
10 other studies available for risedronic acid and Femoral Fractures
| Article | Year |
|---|---|
Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; | 2021 |
Bisphosphonate-associated atypical subtrochanteric femur fractures in the older patient.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Femoral | 2014 |
Risk of atypical femoral fracture during and after bisphosphonate use.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Case-Control Studies; Cohort | 2015 |
Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study.
Topics: Absorptiometry, Photon; Aged; Alendronate; Arthritis, Rheumatoid; Bone Density; Bone Density Conserv | 2016 |
Location of fractures and the characteristics of patients with atypical femoral fractures: analyses of 38 Japanese cases.
Topics: Aged; Aged, 80 and over; Alendronate; Asian People; Bone Density Conservation Agents; Bone Remodelin | 2017 |
Atypical femoral fractures and bisphosphonate use.
Topics: Aged; Aged, 80 and over; Alendronate; Diphosphonates; Etidronic Acid; Female; Femoral Fractures; Hum | 2010 |
Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
Topics: Alendronate; Bone Density Conservation Agents; Bone Nails; Bone Resorption; Etidronic Acid; Female; | 2010 |
[Bilateral pathological sub-trochanteric fracture in a long-term biphosphonate user].
Topics: Aged; Bone Density Conservation Agents; Etidronic Acid; Female; Femoral Fractures; Fractures, Sponta | 2011 |
Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
Topics: Administration, Oral; Aged; Alendronate; Cohort Studies; Diphosphonates; Drug Administration Schedul | 2012 |
[Weeks of pain, vertebral body fractures during sleep, invalidism. Save your osteoporosis patients from this fate].
Topics: Activities of Daily Living; Age Factors; Alendronate; Analgesics, Opioid; Anti-Inflammatory Agents, | 2002 |